IL300864A

IL300864A - Adeno-associated virus for the administration of KH902 (Conversept) and its uses

Adeno-associated virus for the administration of KH902 (Conversept) and its uses

Info

Publication number: IL300864A
Authority: IL; Israel
Prior art keywords: raav; vegf; capsid protein; mir; fold
Prior art date: 2020-09-03

Application number

IL300864A

Other languages

English (en)

Hebrew (he)

Original Assignee

Univ Massachusetts

Priority date

2020-09-03

Filing date

2021-09-02

Publication date

2023-04-01

2021-09-02 Application filed by Univ Massachusetts filed Critical Univ Massachusetts

2023-04-01 Publication of IL300864A publication Critical patent/IL300864A/en

Links

241000702421 Dependoparvovirus Species 0.000 title claims description 26
108700036276 KH902 fusion Proteins 0.000 title description 29
229950005748 conbercept Drugs 0.000 title description 27
108090000565 Capsid Proteins Proteins 0.000 claims description 140
102100023321 Ceruloplasmin Human genes 0.000 claims description 140
239000003795 chemical substances by application Substances 0.000 claims description 135
150000007523 nucleic acids Chemical class 0.000 claims description 132
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 113
238000002347 injection Methods 0.000 claims description 113
239000007924 injection Substances 0.000 claims description 113
108700019146 Transgenes Proteins 0.000 claims description 108
241000702423 Adeno-associated virus - 2 Species 0.000 claims description 106
125000003275 alpha amino acid group Chemical group 0.000 claims description 105
201000000159 corneal neovascularization Diseases 0.000 claims description 105
238000000034 method Methods 0.000 claims description 105
206010055665 Corneal neovascularisation Diseases 0.000 claims description 101
210000004027 cell Anatomy 0.000 claims description 101
210000004087 cornea Anatomy 0.000 claims description 96
102000039446 nucleic acids Human genes 0.000 claims description 82
108020004707 nucleic acids Proteins 0.000 claims description 82
108090000623 proteins and genes Proteins 0.000 claims description 64
239000013598 vector Substances 0.000 claims description 61
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 55
108091028043 Nucleic acid sequence Proteins 0.000 claims description 52
201000010099 disease Diseases 0.000 claims description 52
101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims description 51
102000058223 human VEGFA Human genes 0.000 claims description 51
102000004169 proteins and genes Human genes 0.000 claims description 43
102000005962 receptors Human genes 0.000 claims description 41
108020003175 receptors Proteins 0.000 claims description 41
241000699666 Mus <mouse, genus> Species 0.000 claims description 40
230000033115 angiogenesis Effects 0.000 claims description 39
241000701022 Cytomegalovirus Species 0.000 claims description 38
230000000694 effects Effects 0.000 claims description 38
108020001507 fusion proteins Proteins 0.000 claims description 37
102000037865 fusion proteins Human genes 0.000 claims description 37
239000002679 microRNA Substances 0.000 claims description 34
230000027455 binding Effects 0.000 claims description 33
108091070501 miRNA Proteins 0.000 claims description 33
108020004705 Codon Proteins 0.000 claims description 32
108700015048 receptor decoy activity proteins Proteins 0.000 claims description 32
238000004806 packaging method and process Methods 0.000 claims description 31
101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 claims description 28
241000282414 Homo sapiens Species 0.000 claims description 27
239000008194 pharmaceutical composition Substances 0.000 claims description 25
241001164825 Adeno-associated virus - 8 Species 0.000 claims description 20
241000283973 Oryctolagus cuniculus Species 0.000 claims description 20
108060003951 Immunoglobulin Proteins 0.000 claims description 19
102000018358 immunoglobulin Human genes 0.000 claims description 19
210000001525 retina Anatomy 0.000 claims description 19
210000002865 immune cell Anatomy 0.000 claims description 17
230000005764 inhibitory process Effects 0.000 claims description 17
239000003623 enhancer Substances 0.000 claims description 16
230000002137 anti-vascular effect Effects 0.000 claims description 14
108010041308 Endothelial Growth Factors Proteins 0.000 claims description 12
-1 miR-19b-l Proteins 0.000 claims description 12
206010029113 Neovascularisation Diseases 0.000 claims description 11
108010082093 Placenta Growth Factor Proteins 0.000 claims description 11
241000283707 Capra Species 0.000 claims description 10
102000007469 Actins Human genes 0.000 claims description 9
108010085238 Actins Proteins 0.000 claims description 9
230000001965 increasing effect Effects 0.000 claims description 9
208000005590 Choroidal Neovascularization Diseases 0.000 claims description 8
206010060823 Choroidal neovascularisation Diseases 0.000 claims description 8
241000287828 Gallus gallus Species 0.000 claims description 8
206010028980 Neoplasm Diseases 0.000 claims description 8
210000002569 neuron Anatomy 0.000 claims description 8
238000011200 topical administration Methods 0.000 claims description 8
108020005345 3' Untranslated Regions Proteins 0.000 claims description 7
241001634120 Adeno-associated virus - 5 Species 0.000 claims description 7
241000972680 Adeno-associated virus - 6 Species 0.000 claims description 7
230000001684 chronic effect Effects 0.000 claims description 7
239000012530 fluid Substances 0.000 claims description 7
230000002401 inhibitory effect Effects 0.000 claims description 7
238000010253 intravenous injection Methods 0.000 claims description 7
108091092195 Intron Proteins 0.000 claims description 6
108091028049 Mir-221 microRNA Proteins 0.000 claims description 6
208000000208 Wet Macular Degeneration Diseases 0.000 claims description 6
210000000795 conjunctiva Anatomy 0.000 claims description 6
238000010255 intramuscular injection Methods 0.000 claims description 6
239000007927 intramuscular injection Substances 0.000 claims description 6
210000001328 optic nerve Anatomy 0.000 claims description 6
210000003786 sclera Anatomy 0.000 claims description 6
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
241000202702 Adeno-associated virus - 3 Species 0.000 claims description 5
102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 5
108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 5
206010025421 Macule Diseases 0.000 claims description 5
241001494479 Pecora Species 0.000 claims description 5
206010038923 Retinopathy Diseases 0.000 claims description 5
108091036066 Three prime untranslated region Proteins 0.000 claims description 5
210000003161 choroid Anatomy 0.000 claims description 5
210000004240 ciliary body Anatomy 0.000 claims description 5
239000003937 drug carrier Substances 0.000 claims description 5
210000004962 mammalian cell Anatomy 0.000 claims description 5
210000001747 pupil Anatomy 0.000 claims description 5
210000004127 vitreous body Anatomy 0.000 claims description 5
241000283690 Bos taurus Species 0.000 claims description 4
241000700199 Cavia porcellus Species 0.000 claims description 4
241000699800 Cricetinae Species 0.000 claims description 4
241000283073 Equus caballus Species 0.000 claims description 4
241000282326 Felis catus Species 0.000 claims description 4
241000238631 Hexapoda Species 0.000 claims description 4
108091046841 MiR-150 Proteins 0.000 claims description 4
108091033773 MiR-155 Proteins 0.000 claims description 4
108091062140 Mir-223 Proteins 0.000 claims description 4
241000009328 Perro Species 0.000 claims description 4
241000700159 Rattus Species 0.000 claims description 4
208000017442 Retinal disease Diseases 0.000 claims description 4
241000282898 Sus scrofa Species 0.000 claims description 4
230000001580 bacterial effect Effects 0.000 claims description 4
230000002601 intratumoral effect Effects 0.000 claims description 4
108091031103 miR-181a stem-loop Proteins 0.000 claims description 4
108091046591 miR-181a-4 stem-loop Proteins 0.000 claims description 4
108091049627 miR-181a-5 stem-loop Proteins 0.000 claims description 4
230000010415 tropism Effects 0.000 claims description 4
241001655883 Adeno-associated virus - 1 Species 0.000 claims description 3
108091060585 Mir-31 Proteins 0.000 claims description 3
201000011510 cancer Diseases 0.000 claims description 3
108091042844 let-7i stem-loop Proteins 0.000 claims description 3
108091064157 miR-106a stem-loop Proteins 0.000 claims description 3
108091044988 miR-125a stem-loop Proteins 0.000 claims description 3
108091049513 miR-125a-1 stem-loop Proteins 0.000 claims description 3
108091040046 miR-125a-2 stem-loop Proteins 0.000 claims description 3
108091032320 miR-146 stem-loop Proteins 0.000 claims description 3
108091024530 miR-146a stem-loop Proteins 0.000 claims description 3
108091089860 miR-148 stem-loop Proteins 0.000 claims description 3
108091037426 miR-152 stem-loop Proteins 0.000 claims description 3
108091091751 miR-17 stem-loop Proteins 0.000 claims description 3
108091069239 miR-17-2 stem-loop Proteins 0.000 claims description 3
108091050874 miR-19a stem-loop Proteins 0.000 claims description 3
108091086850 miR-19a-1 stem-loop Proteins 0.000 claims description 3
108091088468 miR-19a-2 stem-loop Proteins 0.000 claims description 3
108091061917 miR-221 stem-loop Proteins 0.000 claims description 3
108091063489 miR-221-1 stem-loop Proteins 0.000 claims description 3
108091055391 miR-221-2 stem-loop Proteins 0.000 claims description 3
108091031076 miR-221-3 stem-loop Proteins 0.000 claims description 3
108091080321 miR-222 stem-loop Proteins 0.000 claims description 3
108091088477 miR-29a stem-loop Proteins 0.000 claims description 3
108091029716 miR-29a-1 stem-loop Proteins 0.000 claims description 3
108091092089 miR-29a-2 stem-loop Proteins 0.000 claims description 3
108091066559 miR-29a-3 stem-loop Proteins 0.000 claims description 3
108091063344 miR-30b stem-loop Proteins 0.000 claims description 3
108091029119 miR-34a stem-loop Proteins 0.000 claims description 3
108091030938 miR-424 stem-loop Proteins 0.000 claims description 3
238000007910 systemic administration Methods 0.000 claims description 3
210000005253 yeast cell Anatomy 0.000 claims description 3
208000001344 Macular Edema Diseases 0.000 claims description 2
206010025415 Macular oedema Diseases 0.000 claims description 2
201000010230 macular retinal edema Diseases 0.000 claims description 2
108091079658 miR-142-1 stem-loop Proteins 0.000 claims description 2
108091071830 miR-142-2 stem-loop Proteins 0.000 claims description 2
108091074057 miR-16-1 stem-loop Proteins 0.000 claims description 2
108091041042 miR-18 stem-loop Proteins 0.000 claims description 2
108091062221 miR-18a stem-loop Proteins 0.000 claims description 2
108091049679 miR-20a stem-loop Proteins 0.000 claims description 2
108091062762 miR-21 stem-loop Proteins 0.000 claims description 2
108091041631 miR-21-1 stem-loop Proteins 0.000 claims description 2
108091044442 miR-21-2 stem-loop Proteins 0.000 claims description 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 12
102000003666 Placenta Growth Factor Human genes 0.000 claims 5
230000014509 gene expression Effects 0.000 description 127
102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 description 107
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 107
229940090044 injection Drugs 0.000 description 95
108091008605 VEGF receptors Proteins 0.000 description 82
102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 78
210000001508 eye Anatomy 0.000 description 74
239000000203 mixture Substances 0.000 description 65
210000001519 tissue Anatomy 0.000 description 60
210000000234 capsid Anatomy 0.000 description 49
239000013612 plasmid Substances 0.000 description 41
239000002953 phosphate buffered saline Substances 0.000 description 32
238000011282 treatment Methods 0.000 description 32
239000013608 rAAV vector Substances 0.000 description 29
241000699670 Mus sp. Species 0.000 description 28
241001465754 Metazoa Species 0.000 description 25
230000003902 lesion Effects 0.000 description 25
239000013647 rAAV8 vector Substances 0.000 description 24
239000013646 rAAV2 vector Substances 0.000 description 23
150000001413 amino acids Chemical class 0.000 description 21
238000010361 transduction Methods 0.000 description 21
230000026683 transduction Effects 0.000 description 21
239000003513 alkali Substances 0.000 description 20
230000006870 function Effects 0.000 description 20
239000003814 drug Substances 0.000 description 18
230000001404 mediated effect Effects 0.000 description 17
230000006378 damage Effects 0.000 description 16
229940079593 drug Drugs 0.000 description 16
230000001105 regulatory effect Effects 0.000 description 16
210000002845 virion Anatomy 0.000 description 16
108020004414 DNA Proteins 0.000 description 15
210000004204 blood vessel Anatomy 0.000 description 13
239000000243 solution Substances 0.000 description 13
230000001225 therapeutic effect Effects 0.000 description 13
238000013518 transcription Methods 0.000 description 12
230000035897 transcription Effects 0.000 description 12
102100031968 Ephrin type-B receptor 2 Human genes 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 11
238000012217 deletion Methods 0.000 description 11
230000037430 deletion Effects 0.000 description 11
238000009472 formulation Methods 0.000 description 11
239000002502 liposome Substances 0.000 description 11
239000002773 nucleotide Substances 0.000 description 11
125000003729 nucleotide group Chemical group 0.000 description 11
238000012014 optical coherence tomography Methods 0.000 description 11
238000004458 analytical method Methods 0.000 description 10
238000011161 development Methods 0.000 description 10
230000018109 developmental process Effects 0.000 description 10
239000003889 eye drop Substances 0.000 description 10
208000014674 injury Diseases 0.000 description 10
239000013607 AAV vector Substances 0.000 description 9
101150053510 ITR1 gene Proteins 0.000 description 9
102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 9
230000004913 activation Effects 0.000 description 9
108010048367 enhanced green fluorescent protein Proteins 0.000 description 9
238000003384 imaging method Methods 0.000 description 9
MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 9
108020004999 messenger RNA Proteins 0.000 description 9
230000011664 signaling Effects 0.000 description 9
230000003612 virological effect Effects 0.000 description 9
108091026890 Coding region Proteins 0.000 description 8
108700028146 Genetic Enhancer Elements Proteins 0.000 description 8
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
102100035194 Placenta growth factor Human genes 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 8
230000001594 aberrant effect Effects 0.000 description 8
210000000612 antigen-presenting cell Anatomy 0.000 description 8
210000002889 endothelial cell Anatomy 0.000 description 8
238000005516 engineering process Methods 0.000 description 8
210000002919 epithelial cell Anatomy 0.000 description 8
230000028993 immune response Effects 0.000 description 8
230000001939 inductive effect Effects 0.000 description 8
230000007170 pathology Effects 0.000 description 8
230000008685 targeting Effects 0.000 description 8
238000011144 upstream manufacturing Methods 0.000 description 8
238000001262 western blot Methods 0.000 description 8
102000014736 Notch Human genes 0.000 description 7
108010070047 Notch Receptors Proteins 0.000 description 7
206010030113 Oedema Diseases 0.000 description 7
208000027418 Wounds and injury Diseases 0.000 description 7
DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 7
229960003120 clonazepam Drugs 0.000 description 7
229940062717 keppra Drugs 0.000 description 7
HPHUVLMMVZITSG-LURJTMIESA-N levetiracetam Chemical compound CC[C@@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-LURJTMIESA-N 0.000 description 7
239000003550 marker Substances 0.000 description 7
239000000463 material Substances 0.000 description 7
UQRORFVVSGFNRO-UTINFBMNSA-N miglustat Chemical compound CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO UQRORFVVSGFNRO-UTINFBMNSA-N 0.000 description 7
229960001512 miglustat Drugs 0.000 description 7
238000003752 polymerase chain reaction Methods 0.000 description 7
229940032668 prevacid Drugs 0.000 description 7
239000000047 product Substances 0.000 description 7
230000002207 retinal effect Effects 0.000 description 7
230000000699 topical effect Effects 0.000 description 7
230000006459 vascular development Effects 0.000 description 7
230000003442 weekly effect Effects 0.000 description 7
206010062016 Immunosuppression Diseases 0.000 description 6
206010038933 Retinopathy of prematurity Diseases 0.000 description 6
210000005252 bulbus oculi Anatomy 0.000 description 6
238000011304 droplet digital PCR Methods 0.000 description 6
238000001415 gene therapy Methods 0.000 description 6
230000001506 immunosuppresive effect Effects 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
238000010348 incorporation Methods 0.000 description 6
238000003780 insertion Methods 0.000 description 6
230000037431 insertion Effects 0.000 description 6
230000035168 lymphangiogenesis Effects 0.000 description 6
239000012528 membrane Substances 0.000 description 6
210000004379 membrane Anatomy 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
238000006467 substitution reaction Methods 0.000 description 6
208000024891 symptom Diseases 0.000 description 6
238000002560 therapeutic procedure Methods 0.000 description 6
230000002792 vascular Effects 0.000 description 6
239000003981 vehicle Substances 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
206010002329 Aneurysm Diseases 0.000 description 5
102100026849 Lymphatic vessel endothelial hyaluronic acid receptor 1 Human genes 0.000 description 5
101710178181 Lymphatic vessel endothelial hyaluronic acid receptor 1 Proteins 0.000 description 5
241000700605 Viruses Species 0.000 description 5
230000005754 cellular signaling Effects 0.000 description 5
230000000875 corresponding effect Effects 0.000 description 5
230000029087 digestion Effects 0.000 description 5
238000010790 dilution Methods 0.000 description 5
239000012895 dilution Substances 0.000 description 5
239000006185 dispersion Substances 0.000 description 5
230000000222 hyperoxic effect Effects 0.000 description 5
238000001727 in vivo Methods 0.000 description 5
230000006698 induction Effects 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
238000007918 intramuscular administration Methods 0.000 description 5
239000003446 ligand Substances 0.000 description 5
210000001365 lymphatic vessel Anatomy 0.000 description 5
210000002540 macrophage Anatomy 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
238000010172 mouse model Methods 0.000 description 5
230000035772 mutation Effects 0.000 description 5
239000002245 particle Substances 0.000 description 5
230000001575 pathological effect Effects 0.000 description 5
230000000649 photocoagulation Effects 0.000 description 5
210000000608 photoreceptor cell Anatomy 0.000 description 5
230000008569 process Effects 0.000 description 5
238000011002 quantification Methods 0.000 description 5
210000003583 retinal pigment epithelium Anatomy 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
238000010186 staining Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
230000002459 sustained effect Effects 0.000 description 5
230000002123 temporal effect Effects 0.000 description 5
210000002262 tip cell Anatomy 0.000 description 5
238000012546 transfer Methods 0.000 description 5
210000005166 vasculature Anatomy 0.000 description 5
102100026031 Beta-glucuronidase Human genes 0.000 description 4
108091004242 G-Protein-Coupled Receptor Kinase 1 Proteins 0.000 description 4
102000004437 G-Protein-Coupled Receptor Kinase 1 Human genes 0.000 description 4
101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 description 4
206010058490 Hyperoxia Diseases 0.000 description 4
206010061218 Inflammation Diseases 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 4
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 4
102000009572 RNA Polymerase II Human genes 0.000 description 4
108010009460 RNA Polymerase II Proteins 0.000 description 4
108090000799 Rhodopsin kinases Proteins 0.000 description 4
239000013504 Triton X-100 Substances 0.000 description 4
229920004890 Triton X-100 Polymers 0.000 description 4
102100035071 Vimentin Human genes 0.000 description 4
108010065472 Vimentin Proteins 0.000 description 4
239000002253 acid Substances 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
238000002583 angiography Methods 0.000 description 4
230000001772 anti-angiogenic effect Effects 0.000 description 4
210000001742 aqueous humor Anatomy 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
238000003556 assay Methods 0.000 description 4
230000037396 body weight Effects 0.000 description 4
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
238000010367 cloning Methods 0.000 description 4
239000003636 conditioned culture medium Substances 0.000 description 4
210000003683 corneal stroma Anatomy 0.000 description 4
238000006471 dimerization reaction Methods 0.000 description 4
230000003511 endothelial effect Effects 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
238000000799 fluorescence microscopy Methods 0.000 description 4
238000001502 gel electrophoresis Methods 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
230000012010 growth Effects 0.000 description 4
210000000987 immune system Anatomy 0.000 description 4
230000004054 inflammatory process Effects 0.000 description 4
239000004615 ingredient Substances 0.000 description 4
238000007689 inspection Methods 0.000 description 4
239000007928 intraperitoneal injection Substances 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
230000009467 reduction Effects 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
230000010076 replication Effects 0.000 description 4
239000000523 sample Substances 0.000 description 4
238000001228 spectrum Methods 0.000 description 4
230000000638 stimulation Effects 0.000 description 4
238000001890 transfection Methods 0.000 description 4
230000006439 vascular pathology Effects 0.000 description 4
210000005048 vimentin Anatomy 0.000 description 4
241000580270 Adeno-associated virus - 4 Species 0.000 description 3
206010011703 Cyanosis Diseases 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
108091029865 Exogenous DNA Proteins 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
108700039691 Genetic Promoter Regions Proteins 0.000 description 3
241000282560 Macaca mulatta Species 0.000 description 3
108010069381 Platelet Endothelial Cell Adhesion Molecule-1 Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
241000714474 Rous sarcoma virus Species 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
108091008874 T cell receptors Proteins 0.000 description 3
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 3
102100024219 T-cell surface glycoprotein CD1a Human genes 0.000 description 3
210000001744 T-lymphocyte Anatomy 0.000 description 3
102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 3
108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 3
108010053100 Vascular Endothelial Growth Factor Receptor-3 Proteins 0.000 description 3
102100033179 Vascular endothelial growth factor receptor 3 Human genes 0.000 description 3
230000009471 action Effects 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
239000008280 blood Substances 0.000 description 3
239000000872 buffer Substances 0.000 description 3
230000005101 cell tropism Effects 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
238000013461 design Methods 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
239000002612 dispersion medium Substances 0.000 description 3
239000000499 gel Substances 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
235000011187 glycerol Nutrition 0.000 description 3
239000003102 growth factor Substances 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
230000003834 intracellular effect Effects 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
206010023332 keratitis Diseases 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
239000007788 liquid Substances 0.000 description 3
210000002751 lymph Anatomy 0.000 description 3
239000006166 lysate Substances 0.000 description 3
239000002609 medium Substances 0.000 description 3
244000005700 microbiome Species 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
210000001616 monocyte Anatomy 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
239000002088 nanocapsule Substances 0.000 description 3
238000002577 ophthalmoscopy Methods 0.000 description 3
239000000843 powder Substances 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 3
238000011160 research Methods 0.000 description 3
230000001177 retroviral effect Effects 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
102000034285 signal transducing proteins Human genes 0.000 description 3
108091006024 signal transducing proteins Proteins 0.000 description 3
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 3
229960002930 sirolimus Drugs 0.000 description 3
239000002904 solvent Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
238000012360 testing method Methods 0.000 description 3
230000005100 tissue tropism Effects 0.000 description 3
230000014616 translation Effects 0.000 description 3
230000008733 trauma Effects 0.000 description 3
238000011269 treatment regimen Methods 0.000 description 3
230000004862 vasculogenesis Effects 0.000 description 3
BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 description 2
CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 2
HFDKKNHCYWNNNQ-YOGANYHLSA-N 75976-10-2 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 HFDKKNHCYWNNNQ-YOGANYHLSA-N 0.000 description 2
241001164823 Adeno-associated virus - 7 Species 0.000 description 2
239000012110 Alexa Fluor 594 Substances 0.000 description 2
241001339993 Anelloviridae Species 0.000 description 2
102100025218 B-cell differentiation antigen CD72 Human genes 0.000 description 2
102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
101150044789 Cap gene Proteins 0.000 description 2
208000018380 Chemical injury Diseases 0.000 description 2
208000028006 Corneal injury Diseases 0.000 description 2
102100036912 Desmin Human genes 0.000 description 2
108010044052 Desmin Proteins 0.000 description 2
206010013774 Dry eye Diseases 0.000 description 2
241000283074 Equus asinus Species 0.000 description 2
241000233866 Fungi Species 0.000 description 2
101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 description 2
101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 2
101000595923 Homo sapiens Placenta growth factor Proteins 0.000 description 2
101000837639 Homo sapiens Thyroxine-binding globulin Proteins 0.000 description 2
102000016844 Immunoglobulin-like domains Human genes 0.000 description 2
108050006430 Immunoglobulin-like domains Proteins 0.000 description 2
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 2
206010072138 Limbal stem cell deficiency Diseases 0.000 description 2
241000282567 Macaca fascicularis Species 0.000 description 2
FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 2
101100310285 Mus musculus St3gal5 gene Proteins 0.000 description 2
238000013355 OIR mouse model Methods 0.000 description 2
208000022873 Ocular disease Diseases 0.000 description 2
102000018886 Pancreatic Polypeptide Human genes 0.000 description 2
201000010183 Papilledema Diseases 0.000 description 2
241000233805 Phoenix Species 0.000 description 2
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 2
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 2
229920000153 Povidone-iodine Polymers 0.000 description 2
KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 2
ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
102100038247 Retinol-binding protein 3 Human genes 0.000 description 2
101710111169 Retinoschisin Proteins 0.000 description 2
102100039507 Retinoschisin Human genes 0.000 description 2
108091081021 Sense strand Proteins 0.000 description 2
241000700584 Simplexvirus Species 0.000 description 2
108010087230 Sincalide Proteins 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
108091081024 Start codon Proteins 0.000 description 2
RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 description 2
102100028709 Thyroxine-binding globulin Human genes 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 2
208000025865 Ulcer Diseases 0.000 description 2
206010046851 Uveitis Diseases 0.000 description 2
108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 description 2
102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
230000002411 adverse Effects 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
102000013529 alpha-Fetoproteins Human genes 0.000 description 2
108010026331 alpha-Fetoproteins Proteins 0.000 description 2
238000010171 animal model Methods 0.000 description 2
210000002159 anterior chamber Anatomy 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000003429 antifungal agent Substances 0.000 description 2
239000012736 aqueous medium Substances 0.000 description 2
210000001367 artery Anatomy 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
229960000397 bevacizumab Drugs 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000008236 biological pathway Effects 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
239000000969 carrier Substances 0.000 description 2
238000010609 cell counting kit-8 assay Methods 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
210000003986 cell retinal photoreceptor Anatomy 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
229960004926 chlorobutanol Drugs 0.000 description 2
229940047766 co-trimoxazole Drugs 0.000 description 2
238000000576 coating method Methods 0.000 description 2
208000021921 corneal disease Diseases 0.000 description 2
210000000399 corneal endothelial cell Anatomy 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000001934 delay Effects 0.000 description 2
210000001787 dendrite Anatomy 0.000 description 2
210000005045 desmin Anatomy 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
238000002224 dissection Methods 0.000 description 2
238000009826 distribution Methods 0.000 description 2
238000001647 drug administration Methods 0.000 description 2
238000012377 drug delivery Methods 0.000 description 2
238000001378 electrochemiluminescence detection Methods 0.000 description 2
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
208000030533 eye disease Diseases 0.000 description 2
229940012356 eye drops Drugs 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
238000013534 fluorescein angiography Methods 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
238000001476 gene delivery Methods 0.000 description 2
238000002695 general anesthesia Methods 0.000 description 2
230000036541 health Effects 0.000 description 2
238000000265 homogenisation Methods 0.000 description 2
238000010185 immunofluorescence analysis Methods 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
238000003364 immunohistochemistry Methods 0.000 description 2
238000012744 immunostaining Methods 0.000 description 2
239000003018 immunosuppressive agent Substances 0.000 description 2
238000001802 infusion Methods 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
239000012212 insulator Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000010354 integration Effects 0.000 description 2
108010048996 interstitial retinol-binding protein Proteins 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
239000007951 isotonicity adjuster Substances 0.000 description 2
229960003299 ketamine Drugs 0.000 description 2
229960003174 lansoprazole Drugs 0.000 description 2
238000010859 live-cell imaging Methods 0.000 description 2
230000007774 longterm Effects 0.000 description 2
238000005259 measurement Methods 0.000 description 2
238000002483 medication Methods 0.000 description 2
108091050734 miR-652 stem-loop Proteins 0.000 description 2
108091089992 miR-9-1 stem-loop Proteins 0.000 description 2
108091071572 miR-9-2 stem-loop Proteins 0.000 description 2
108091076838 miR-9-3 stem-loop Proteins 0.000 description 2
108091060187 miR-9-5 stem-loop Proteins 0.000 description 2
108091058972 miR-9-6 stem-loop Proteins 0.000 description 2
108091007420 miR‐142 Proteins 0.000 description 2
238000009126 molecular therapy Methods 0.000 description 2
239000002105 nanoparticle Substances 0.000 description 2
208000015122 neurodegenerative disease Diseases 0.000 description 2
230000002018 overexpression Effects 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
230000010412 perfusion Effects 0.000 description 2
210000003668 pericyte Anatomy 0.000 description 2
229960003742 phenol Drugs 0.000 description 2
108010079892 phosphoglycerol kinase Proteins 0.000 description 2
108091008695 photoreceptors Proteins 0.000 description 2
230000035790 physiological processes and functions Effects 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
229920002981 polyvinylidene fluoride Polymers 0.000 description 2
229960001621 povidone-iodine Drugs 0.000 description 2
229960005205 prednisolone Drugs 0.000 description 2
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
229960004618 prednisone Drugs 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
229960003981 proparacaine Drugs 0.000 description 2
229960003876 ranibizumab Drugs 0.000 description 2
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
239000000790 retinal pigment Substances 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
229960004641 rituximab Drugs 0.000 description 2
201000000306 sarcoidosis Diseases 0.000 description 2
230000037390 scarring Effects 0.000 description 2
238000012764 semi-quantitative analysis Methods 0.000 description 2
IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
235000010199 sorbic acid Nutrition 0.000 description 2
229940075582 sorbic acid Drugs 0.000 description 2
239000004334 sorbic acid Substances 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
210000004158 stalk cell Anatomy 0.000 description 2
150000003431 steroids Chemical class 0.000 description 2
238000003860 storage Methods 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
108010037298 thymic shared antigen-2 Proteins 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
231100000397 ulcer Toxicity 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
238000005406 washing Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
230000029663 wound healing Effects 0.000 description 2
BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 2
229960001600 xylazine Drugs 0.000 description 2
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 1
102100028187 ATP-binding cassette sub-family C member 6 Human genes 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
241000649044 Adeno-associated virus 9 Species 0.000 description 1
206010001257 Adenoviral conjunctivitis Diseases 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
239000012103 Alexa Fluor 488 Substances 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
208000003120 Angiofibroma Diseases 0.000 description 1
208000002109 Argyria Diseases 0.000 description 1
206010003645 Atopy Diseases 0.000 description 1
102100038080 B-cell receptor CD22 Human genes 0.000 description 1
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 1
208000009137 Behcet syndrome Diseases 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
102100027207 CD27 antigen Human genes 0.000 description 1
210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
101100289995 Caenorhabditis elegans mac-1 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
208000009043 Chemical Burns Diseases 0.000 description 1
208000002691 Choroiditis Diseases 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
206010069729 Collateral circulation Diseases 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
108010003730 Cone Opsins Proteins 0.000 description 1
206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
208000006069 Corneal Opacity Diseases 0.000 description 1
206010011017 Corneal graft rejection Diseases 0.000 description 1
206010061788 Corneal infection Diseases 0.000 description 1
206010011044 Corneal scar Diseases 0.000 description 1
102000004420 Creatine Kinase Human genes 0.000 description 1
108010042126 Creatine kinase Proteins 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
206010012689 Diabetic retinopathy Diseases 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
208000003556 Dry Eye Syndromes Diseases 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
208000019878 Eales disease Diseases 0.000 description 1
UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102100027581 Forkhead box protein P3 Human genes 0.000 description 1
102100024405 GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Human genes 0.000 description 1
102100021260 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Human genes 0.000 description 1
208000003098 Ganglion Cysts Diseases 0.000 description 1
208000010412 Glaucoma Diseases 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102400000321 Glucagon Human genes 0.000 description 1
108060003199 Glucagon Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102000006354 HLA-DR Antigens Human genes 0.000 description 1
108010058597 HLA-DR Antigens Proteins 0.000 description 1
208000037952 HSV-1 infection Diseases 0.000 description 1
101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
201000002563 Histoplasmosis Diseases 0.000 description 1
101001080179 Homo sapiens 60S ribosomal protein L26 Proteins 0.000 description 1
101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 description 1
101000981252 Homo sapiens GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 1
101000894906 Homo sapiens Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Proteins 0.000 description 1
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
101000979333 Homo sapiens Neurofilament light polypeptide Proteins 0.000 description 1
101001001487 Homo sapiens Phosphatidylinositol-glycan biosynthesis class F protein Proteins 0.000 description 1
101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 description 1
101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 1
101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 1
101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
206010051151 Hyperviscosity syndrome Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102000016921 Integrin-Binding Sialoprotein Human genes 0.000 description 1
108010028750 Integrin-Binding Sialoprotein Proteins 0.000 description 1
102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
108010032774 Interleukin-2 Receptor alpha Subunit Proteins 0.000 description 1
102000007351 Interleukin-2 Receptor alpha Subunit Human genes 0.000 description 1
108010025815 Kanamycin Kinase Proteins 0.000 description 1
208000007766 Kaposi sarcoma Diseases 0.000 description 1
208000008839 Kidney Neoplasms Diseases 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
239000002147 L01XE04 - Sunitinib Substances 0.000 description 1
239000005511 L01XE05 - Sorafenib Substances 0.000 description 1
239000002136 L01XE07 - Lapatinib Substances 0.000 description 1
239000003798 L01XE11 - Pazopanib Substances 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
101150022930 M17 gene Proteins 0.000 description 1
102000019149 MAP kinase activity proteins Human genes 0.000 description 1
108040008097 MAP kinase activity proteins Proteins 0.000 description 1
241000282553 Macaca Species 0.000 description 1
206010025412 Macular dystrophy congenital Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
108091007780 MiR-122 Proteins 0.000 description 1
108700011259 MicroRNAs Proteins 0.000 description 1
208000024599 Mooren ulcer Diseases 0.000 description 1
241000713333 Mouse mammary tumor virus Species 0.000 description 1
101100121460 Mus musculus Gcsam gene Proteins 0.000 description 1
101100351020 Mus musculus Pax5 gene Proteins 0.000 description 1
101100519207 Mus musculus Pdcd1 gene Proteins 0.000 description 1
206010062207 Mycobacterial infection Diseases 0.000 description 1
201000004404 Neurofibroma Diseases 0.000 description 1
230000005913 Notch signaling pathway Effects 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
208000021957 Ocular injury Diseases 0.000 description 1
208000010191 Osteitis Deformans Diseases 0.000 description 1
102000004067 Osteocalcin Human genes 0.000 description 1
108090000573 Osteocalcin Proteins 0.000 description 1
101150044441 PECAM1 gene Proteins 0.000 description 1
108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
208000027868 Paget disease Diseases 0.000 description 1
102100037504 Paired box protein Pax-5 Human genes 0.000 description 1
101710149067 Paired box protein Pax-5 Proteins 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
208000004788 Pars Planitis Diseases 0.000 description 1
208000037273 Pathologic Processes Diseases 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
206010034277 Pemphigoid Diseases 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
102000037602 Platelet Endothelial Cell Adhesion Molecule-1 Human genes 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
208000003971 Posterior uveitis Diseases 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
241000288906 Primates Species 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
208000010362 Protozoan Infections Diseases 0.000 description 1
201000004613 Pseudoxanthoma elasticum Diseases 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
201000002154 Pterygium Diseases 0.000 description 1
206010037649 Pyogenic granuloma Diseases 0.000 description 1
102000014450 RNA Polymerase III Human genes 0.000 description 1
108010078067 RNA Polymerase III Proteins 0.000 description 1
108091005682 Receptor kinases Proteins 0.000 description 1
206010038389 Renal cancer Diseases 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
206010038848 Retinal detachment Diseases 0.000 description 1
206010038886 Retinal oedema Diseases 0.000 description 1
206010038910 Retinitis Diseases 0.000 description 1
102100031176 Retinoid isomerohydrolase Human genes 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
102000014400 SH2 domains Human genes 0.000 description 1
108050003452 SH2 domains Proteins 0.000 description 1
206010039705 Scleritis Diseases 0.000 description 1
102100038081 Signal transducer CD24 Human genes 0.000 description 1
208000021386 Sjogren Syndrome Diseases 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
102000005157 Somatostatin Human genes 0.000 description 1
108010056088 Somatostatin Proteins 0.000 description 1
208000027073 Stargardt disease Diseases 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
102000017299 Synapsin-1 Human genes 0.000 description 1
108050005241 Synapsin-1 Proteins 0.000 description 1
208000005400 Synovial Cyst Diseases 0.000 description 1
102100027208 T-cell antigen CD7 Human genes 0.000 description 1
102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 1
102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
101150052863 THY1 gene Proteins 0.000 description 1
206010043189 Telangiectasia Diseases 0.000 description 1
208000018656 Terrien marginal degeneration Diseases 0.000 description 1
108010022394 Threonine synthase Proteins 0.000 description 1
102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
201000005485 Toxoplasmosis Diseases 0.000 description 1
241000390203 Trachoma Species 0.000 description 1
206010052779 Transplant rejections Diseases 0.000 description 1
102000004987 Troponin T Human genes 0.000 description 1
108090001108 Troponin T Proteins 0.000 description 1
238000010162 Tukey test Methods 0.000 description 1
102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
206010064996 Ulcerative keratitis Diseases 0.000 description 1
101150004676 VGF gene Proteins 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
102000009520 Vascular Endothelial Growth Factor C Human genes 0.000 description 1
108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 description 1
102000009519 Vascular Endothelial Growth Factor D Human genes 0.000 description 1
108010073919 Vascular Endothelial Growth Factor D Proteins 0.000 description 1
206010047571 Visual impairment Diseases 0.000 description 1
208000010011 Vitamin A Deficiency Diseases 0.000 description 1
206010047663 Vitritis Diseases 0.000 description 1
108091093126 WHP Posttrascriptional Response Element Proteins 0.000 description 1
101100351021 Xenopus laevis pax5 gene Proteins 0.000 description 1
239000003070 absorption delaying agent Substances 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
208000004064 acoustic neuroma Diseases 0.000 description 1
239000013543 active substance Substances 0.000 description 1
108010081667 aflibercept Proteins 0.000 description 1
229960002833 aflibercept Drugs 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
239000012637 allosteric effector Substances 0.000 description 1
UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
210000001691 amnion Anatomy 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
210000003484 anatomy Anatomy 0.000 description 1
239000002870 angiogenesis inducing agent Substances 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
210000004507 artificial chromosome Anatomy 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
230000035578 autophosphorylation Effects 0.000 description 1
229960003005 axitinib Drugs 0.000 description 1
RITAVMQDGBJQJZ-FMIVXFBMSA-N axitinib Chemical compound CNC(=O)C1=CC=CC=C1SC1=CC=C(C(\C=C\C=2N=CC=CC=2)=NN2)C2=C1 RITAVMQDGBJQJZ-FMIVXFBMSA-N 0.000 description 1
230000005549 barrier dysfunction Effects 0.000 description 1
210000000270 basal cell Anatomy 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
230000015916 branching morphogenesis of a tube Effects 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
239000002775 capsule Substances 0.000 description 1
229960001631 carbomer Drugs 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
210000005056 cell body Anatomy 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000012292 cell migration Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000004087 circulation Effects 0.000 description 1
108010072917 class-I restricted T cell-associated molecule Proteins 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000011281 clinical therapy Methods 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
238000011260 co-administration Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
230000004453 corneal transparency Effects 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
238000012258 culturing Methods 0.000 description 1
238000011461 current therapy Methods 0.000 description 1
WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
238000013480 data collection Methods 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
230000008021 deposition Effects 0.000 description 1
210000002555 descemet membrane Anatomy 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
229960003957 dexamethasone Drugs 0.000 description 1
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
102000004419 dihydrofolate reductase Human genes 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
230000007783 downstream signaling Effects 0.000 description 1
UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
230000013020 embryo development Effects 0.000 description 1
230000009762 endothelial cell differentiation Effects 0.000 description 1
108091007231 endothelial receptors Proteins 0.000 description 1
210000003352 endothelial tip cell Anatomy 0.000 description 1
210000003989 endothelium vascular Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
208000021373 epidemic keratoconjunctivitis Diseases 0.000 description 1
210000005081 epithelial layer Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
210000003560 epithelium corneal Anatomy 0.000 description 1
229940073505 ethyl vanillin Drugs 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
230000004438 eyesight Effects 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
229960002143 fluorescein Drugs 0.000 description 1
229940020947 fluorescein sodium Drugs 0.000 description 1
238000002073 fluorescence micrograph Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
231100000025 genetic toxicology Toxicity 0.000 description 1
230000001738 genotoxic effect Effects 0.000 description 1
102000018146 globin Human genes 0.000 description 1
108060003196 globin Proteins 0.000 description 1
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
229960004666 glucagon Drugs 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229960005150 glycerol Drugs 0.000 description 1
201000010536 head and neck cancer Diseases 0.000 description 1
208000014829 head and neck neoplasm Diseases 0.000 description 1
210000002443 helper t lymphocyte Anatomy 0.000 description 1
201000011066 hemangioma Diseases 0.000 description 1
230000011132 hemopoiesis Effects 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
208000013653 hyalitis Diseases 0.000 description 1
235000011167 hydrochloric acid Nutrition 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
230000008629 immune suppression Effects 0.000 description 1
238000003125 immunofluorescent labeling Methods 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 1
229960004657 indocyanine green Drugs 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
230000035984 keratolysis Effects 0.000 description 1
201000010982 kidney cancer Diseases 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
229960004891 lapatinib Drugs 0.000 description 1
BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
230000002197 limbic effect Effects 0.000 description 1
210000001232 limbus corneae Anatomy 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
201000007270 liver cancer Diseases 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
208000014018 liver neoplasm Diseases 0.000 description 1
238000010234 longitudinal analysis Methods 0.000 description 1
229940127021 low-dose drug Drugs 0.000 description 1
229940076783 lucentis Drugs 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
108010092763 macromolecular insoluble cold globulin Proteins 0.000 description 1
208000002780 macular degeneration Diseases 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
208000027202 mammary Paget disease Diseases 0.000 description 1
238000007726 management method Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
206010061289 metastatic neoplasm Diseases 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
229960004584 methylprednisolone Drugs 0.000 description 1
108091051828 miR-122 stem-loop Proteins 0.000 description 1
108091047602 miR-126a stem-loop Proteins 0.000 description 1
108091057645 miR-15 stem-loop Proteins 0.000 description 1
108091027943 miR-16 stem-loop Proteins 0.000 description 1
108091027698 miR-18-1 stem-loop Proteins 0.000 description 1
108091090961 miR-18-2 stem-loop Proteins 0.000 description 1
108091037787 miR-19b stem-loop Proteins 0.000 description 1
108091087148 miR-20 stem-loop Proteins 0.000 description 1
108091066984 miR-20-1 stem-loop Proteins 0.000 description 1
108091076199 miR-20-2 stem-loop Proteins 0.000 description 1
108091092825 miR-24 stem-loop Proteins 0.000 description 1
108091048857 miR-24-1 stem-loop Proteins 0.000 description 1
108091047483 miR-24-2 stem-loop Proteins 0.000 description 1
108091048549 miR-29b stem-loop Proteins 0.000 description 1
108091047189 miR-29c stem-loop Proteins 0.000 description 1
108091054490 miR-29c-2 stem-loop Proteins 0.000 description 1
108091084454 miR-302a stem-loop Proteins 0.000 description 1
108091044457 miR-33 stem-loop Proteins 0.000 description 1
108091038446 miR-9-4 stem-loop Proteins 0.000 description 1
108091084642 miR-9-7 stem-loop Proteins 0.000 description 1
108091034121 miR-92a stem-loop Proteins 0.000 description 1
108091041519 miR-92a-3 stem-loop Proteins 0.000 description 1
238000001000 micrograph Methods 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
230000000116 mitigating effect Effects 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
208000027531 mycobacterial infectious disease Diseases 0.000 description 1
230000002107 myocardial effect Effects 0.000 description 1
230000004379 myopia Effects 0.000 description 1
208000001491 myopia Diseases 0.000 description 1
239000002077 nanosphere Substances 0.000 description 1
239000013642 negative control Substances 0.000 description 1
201000003142 neovascular glaucoma Diseases 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
210000004498 neuroglial cell Anatomy 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
230000000414 obstructive effect Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000002674 ointment Substances 0.000 description 1
238000001543 one-way ANOVA Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
238000005457 optimization Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
238000010979 pH adjustment Methods 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
229940090668 parachlorophenol Drugs 0.000 description 1
230000009054 pathological process Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
229960000639 pazopanib Drugs 0.000 description 1
CUIHSIWYWATEQL-UHFFFAOYSA-N pazopanib Chemical compound C1=CC2=C(C)N(C)N=C2C=C1N(C)C(N=1)=CC=NC=1NC1=CC=C(C)C(S(N)(=O)=O)=C1 CUIHSIWYWATEQL-UHFFFAOYSA-N 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
235000011007 phosphoric acid Nutrition 0.000 description 1
150000003016 phosphoric acids Chemical class 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
238000013326 plasmid cotransfection Methods 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920001993 poloxamer 188 Polymers 0.000 description 1
229920000771 poly (alkylcyanoacrylate) Polymers 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
210000003240 portal vein Anatomy 0.000 description 1
239000013641 positive control Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
235000010241 potassium sorbate Nutrition 0.000 description 1
239000004302 potassium sorbate Substances 0.000 description 1
229940069338 potassium sorbate Drugs 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000001023 pro-angiogenic effect Effects 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
239000000473 propyl gallate Substances 0.000 description 1
229940075579 propyl gallate Drugs 0.000 description 1
235000010388 propyl gallate Nutrition 0.000 description 1
238000002331 protein detection Methods 0.000 description 1
208000023558 pseudoxanthoma elasticum (inherited or acquired) Diseases 0.000 description 1
230000010344 pupil dilation Effects 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
230000003439 radiotherapeutic effect Effects 0.000 description 1
108091008598 receptor tyrosine kinases Proteins 0.000 description 1
102000027426 receptor tyrosine kinases Human genes 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
210000005084 renal tissue Anatomy 0.000 description 1
101150066583 rep gene Proteins 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000004264 retinal detachment Effects 0.000 description 1
201000011195 retinal edema Diseases 0.000 description 1
230000004233 retinal vasculature Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
201000004700 rosacea Diseases 0.000 description 1
238000005070 sampling Methods 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
201000006476 shipyard eye Diseases 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
238000009097 single-agent therapy Methods 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229940087854 solu-medrol Drugs 0.000 description 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
229960000553 somatostatin Drugs 0.000 description 1
238000000527 sonication Methods 0.000 description 1
229960003787 sorafenib Drugs 0.000 description 1
241000894007 species Species 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
229940044609 sulfur dioxide Drugs 0.000 description 1
235000010269 sulphur dioxide Nutrition 0.000 description 1
229960001796 sunitinib Drugs 0.000 description 1
WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
230000001839 systemic circulation Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
201000000596 systemic lupus erythematosus Diseases 0.000 description 1
208000009056 telangiectasis Diseases 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
238000002691 topical anesthesia Methods 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
206010044325 trachoma Diseases 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
238000003151 transfection method Methods 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
239000003656 tris buffered saline Substances 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
238000007492 two-way ANOVA Methods 0.000 description 1
239000011882 ultra-fine particle Substances 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
210000003606 umbilical vein Anatomy 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
239000002691 unilamellar liposome Substances 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
208000019553 vascular disease Diseases 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
230000006444 vascular growth Effects 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
238000012795 verification Methods 0.000 description 1
208000029257 vision disease Diseases 0.000 description 1
230000004304 visual acuity Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
230000004382 visual function Effects 0.000 description 1
230000004393 visual impairment Effects 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
201000007790 vitelliform macular dystrophy Diseases 0.000 description 1